Nextech: Funding, Team & Investors | Startup Intros

Loading organizations...

Nextech: Funding, Team & Investors | Startup Intros

Financial History

Total Raised

N/A

Valuation

N/A

Investments Made

Date	Company	Round	Lead Investor(s)	Co-Investor(s)
Oct 1, 2025	Electra Therapeutics	$180.0M Series C	Christoph Broja, Thomas Geninatti	OrbiMed, Westlake Village BioPartners, HBM Healthcare Investments, Mubadala Capital, Sanofi
Mar 1, 2024	Alumis	$260.0M Series C	Foresite Capital, Srinivas Akkaraju	ARCH Venture Partners, Atlas Venture, Deerfield Management, F-Prime Capital Partners, The Column Group, venBio, Ally Bridge Group, AyurMaya, Cormorant Asset Management, HBM Healthcare Investments, Lilly Asia Ventures, Omega Funds, Piper Heartland Healthcare Capital, SR One
Dec 1, 2023	Synnovation Therapeutics	$100.0M Series A	Third Rock Ventures	Johnson & Johnson Innovation, Sofinnova Investments, Cormorant Asset Management, Judith Li, Thilo Schroeder, Ting Feng
Feb 13, 2023	Hexagon Bio	$77.3M Series B	—	8VC, The Column Group, Dusan Perovic
Feb 1, 2023	CARGO Therapeutics	$200.0M Series A	Third Rock Ventures, Perceptive Xontogeny Venture Fund, RTW Investments	Ally Bridge Group, Cormorant Asset Management, Emerson Collective, Janus Henderson Investors, Piper Heartland Healthcare Capital, Red Tree Venture Capital, Samsara BioCapital, T. Rowe Price Associates, Wellington Management
Jan 1, 2021	IconOVir Bio	$77.0M Series A	Vida Ventures, Jakob Loven	Endeavor Venture Funds, Nextech Invest, UpHonest Capital, Bellco Capital, Google Ventures, Logos Capital, Polaris Partners, Joshua Kazam, Wellington Partners
Jun 16, 2020	C4 Therapeutics, Inc.	$170.0M Debt / Series B	Todd Kaloudis, Adam Stone	3E Bioventures Capital, Adage Capital Management, Axil Capital, Bain Capital Life Sciences, Commodore Capital, HBM Healthcare Investments, Janus Henderson Investors, Lightchain Capital, Logos Capital, Mizuho Securities Principal Investment, RA Capital Management, RTW Investments, Sphera Funds Management, T. Rowe Price Associates, Yonjin Capital
Jan 12, 2020	EQRx	$200.0M Series A	Andreessen Horowitz, Arboretum Ventures, ARCH Venture Partners, Casdin Capital, Krishna Yeshwant, Nextech, Section 32	—